DIALYSIS · CCN 332685

USRC TONAWANDA DIALYSIS

Tonawanda, NY 14150

DialysisProfitUS Renal Care, Inc.
$7.5M
TOTAL REVENUE
40.0%
OPERATING MARGIN
4 / 5
STAR RATING
16
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$7.5M
Total costs
$4.5M
Operating income (rev − costs)
$3.0M
Operating margin
40.0%
Total charges
$7.5M
Total treatments
13,688
Dialysis stations
12

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

16 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
9764—
Percentage of Adult PD Patients with Kt/V >= 1.7
DFC_ADULT_PD_KTV
9730—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.7260—
Fistula Rate
DFC_FISTULA_RATE
67.580—
Five Star Rating
DFC_FIVE_STAR
4——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
2.1162—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
132.292—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
1103—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1280—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
22.3355—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
18.982—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
27.986—
Standardized ED Visits Ratio
DFC_SEDR
1.2740—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
37.833—